Cataliotti, Alessandro

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet

Nitric Oxide and Endothelin EffectsDialysis and Renal Disease Management

Cited by 1,087

Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease

Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation

Dialysis and Renal Disease ManagementHeart Failure Treatment and Management

Cited by 519

Targeting obesity and diabetes to treat heart failure with preserved ejection fraction

Altara, R., Giordano, M., Nordén, E. S., Cataliotti, A., Kurdi, M., Bajestani, S. N., & Booz, G. W. (2017) · Frontiers in Endocrinology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 61

Novel enhancers of guanylyl cyclase-A activity via allosteric modulation

Andresen, H., Pérez-Ternero, C., Robinson, J., Dickey, D. M., Hobbs, A. J., Potter, L. R., Levy, F. O., Cataliotti, A., & Moltzau, L. R. (2022) · British Journal of Pharmacology

Receptor Mechanisms and SignalingPhosphodiesterase function and regulation

Cited by 4